Trials / Active Not Recruiting
Active Not RecruitingNCT06054867
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- PROCEPT BioRobotics · Industry
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Robotic Waterjet Treatment | The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System. During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real-time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan. |
Timeline
- Start date
- 2024-03-11
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2023-09-26
- Last updated
- 2024-08-14
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06054867. Inclusion in this directory is not an endorsement.